Message from the President

Pursuing New Possibilities in Reproductive Medicine

The Kitazato Group is a Japanese corporate group that develops and manufactures products related to fertility treatment, supplying our proprietary products to markets around the world. We specialize in reproductive engineering technologies used in artificial insemination, in vitro fertilization, cryopreservation of cells, and regenerative medicine, and we continuously develop products to meet the ever-evolving needs and expectations of the market.

What we regard as our mission, and place the highest importance on, is the pursuit of new possibilities in reproductive medicine.

To fulfill this mission, we engage in collaborative research with physicians and researchers worldwide, strategically leveraging the specialized technologies and knowledge accumulated over many years. Through these efforts, we are committed to both enhancing existing technologies and creating new innovations.

In our global business activities, we promote ISO standards and conduct our operations in full compliance with the laws and regulations of each country, while contributing to the advancement of medical technologies within local communities.

At the same time, we remain constantly mindful of environmental issues, and we are dedicated to growing together with healthcare professionals, sharing success with them, and continuing to evolve as a company that advances alongside the medical community.

We sincerely appreciate your continued guidance and support.

Futoshi INOUE, MBA, Pharm.D., Ph.D.
President and Representative Director
Kitazato Corporation